Back to News
Market Impact: 0.3
Abbott To Separate Its Nutrition Business Into Publicly Traded Company
Source: Nasdaq
M&A & RestructuringManagement & GovernanceCompany Fundamentals
Abbott announced its intention to separate its Nutrition business into an independent, publicly traded company. Daniel Salvadori, currently executive vice president and group president of Established Pharmaceuticals and Nutritional Products, will become the new company's CEO; the article provides no financial terms or timeline.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
ABT0.50
More News
- Stock Movers: Super Micro Computer, SpaceX, Abbot Labs (Podcast)
- Our top 10 things to watch in the stock market Wednesday
- Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded company
- Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance
- The U.S. market has never been more focused on one single bet—but AI’s payoff will likely take decades
- Meta put out an ambitious roadmap to Muse monetization after strong quarter and guide